Emend and Amylase increased - a phase IV clinical study of FDA data

Summary:

Amylase increased is reported as a side effect among people who take Emend (aprepitant), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cancidas, and have Insomnia.

The phase IV clinical study analyzes which people have Amylase increased when taking Emend. It is created by eHealthMe based on reports of 13,708 people who have side effects when taking Emend from the FDA, and is updated regularly.

What is Emend?

Emend has active ingredients of aprepitant. It is often used in nausea. eHealthMe is studying from 13,741 Emend users. Check the latest studies of Emend.

What is Amylase increased?

Amylase increased is found to be associated with 405 drugs and 732 conditions by eHealthMe. Check the latest studies of Amylase increased.

On Jul, 10, 2026

13,708 people reported to have side effects when taking Emend.
Among them, 13 people (0.09%) have Amylase increased.

Among these 13 people:

How long have people been on Emend when they have Amylase increased? *

What is the gender of people who have Amylase increased when taking Emend? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Amylase increased when taking Emend? *

What are other drugs people take besides Emend? *

What are other side effects people have besides Amylase increased? *

Large Intestine Perforation (hole in large intestine): 5 people, 38.46%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 38.46%
Small Intestinal Perforation (hole in small intestine): 5 people, 38.46%
Shock Haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding): 5 people, 38.46%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 38.46%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 23.08%
Gastric Ulcer (stomach ulcer): 3 people, 23.08%
Lipase Increased: 3 people, 23.08%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 3 people, 23.08%
Thrombocytopenia (decrease of platelets in blood): 3 people, 23.08%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 53.85%
Constipation: 7 people, 53.85%
Insomnia (sleeplessness): 7 people, 53.85%
High Blood Pressure: 6 people, 46.15%
Joint Pain: 5 people, 38.46%
Anaesthesia: 5 people, 38.46%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 38.46%
Blood Glucose Increased: 5 people, 38.46%
Dehydration (dryness resulting from the removal of water): 5 people, 38.46%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Emend and have Amylase increased?

- Check whether Amylase increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emend:

Emend (13,741 reports)

Browse all side effects of Emend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Amylase increased:

Amylase increased (405 drugs)

Browse all the conditions that are associated with Amylase increased:

Amylase increased (732 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant (the active ingredients of Emend) and Emend (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.